Rodman & Renshaw Initiates Coverage on Oasmia Pharmaceutical AB – American Depositary Shares to Buy

Rodman & Renshaw Initiates Coverage on Oasmia Pharmaceutical AB – American Depositary Shares(NASDAQ:OASM). The shares have been rated Buy. The rating by Rodman & Renshaw was issued on Sep 12, 2016.

Oasmia Pharmaceutical AB – American Depositary Shares(OASM) last announced its earnings results on Jun 3, 2016 for Fiscal Year 2015 and Q4.Earnings per share were $-0.04.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Oasmia Pharmaceutical AB - American Depositary Shares - Is it time to Sell?

Top Brokerage Firms are advising their investors on Oasmia Pharmaceutical AB - American Depositary Shares. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.